Big Data Investments in the Healthcare and Pharmaceutical Industry Growth $4.7 Billion in 2018 and CAGR of Approximately 12% Over the Next Three Years

USA - English

News provided by

Jul 26, 2018, 11:00 ET

PUNE, India, July 26, 2018 /PRNewswire/ --

ReportsnReports.com adds a new research report of Big Data in the Healthcare & Pharmaceutical Industry: 2018 - 2030 - Opportunities, Challenges, Strategies and Forecasts. The report estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4.7 Billion in 2018 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of approximately 12% over the next three years.

The "Big Data in the Healthcare & Pharmaceutical Industry : 2018 - 2030 - Opportunities, Challenges, Strategies & Forecasts" report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2018 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 37 use cases, 6 regions and 35 countries.

Topics Covered

The report covers the following topics:

Big Data ecosystem
Market drivers and barriers
Enabling technologies, standardization and regulatory initiatives
Big Data analytics and implementation models
Business case, application areas and use cases in the healthcare and pharmaceutical industry
Over 40 case studies of Big Data investments by healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders
Future roadmap and value chain
Profiles and strategies of over 270 leading and emerging Big Data ecosystem players
Strategic recommendations for Big Data vendors, and healthcare and pharmaceutical industry stakeholders
Market analysis and forecasts from 2018 till 2030

For More detail report with their Use cases, Company profile analysis, Forecast Segmentation, Hardware, Software & Professional Services, Horizontal Submarkets, Application Areas, Regional Markets data report direct purchase at http://www.reportsnreports.com/purchase.aspx?name=1581502 .

Key Questions Answered

The report provides answers to the following key questions:

How big is the Big Data opportunity in the healthcare and pharmaceutical industry?
How is the market evolving by segment and region?
What will the market size be in 2021, and at what rate will it grow?
What trends, challenges and barriers are influencing its growth?
Who are the key Big Data software, hardware and services vendors, and what are their strategies?
How much are healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders investing in Big Data?
What opportunities exist for Big Data analytics in the healthcare and pharmaceutical industry?
Which countries, application areas and use cases will see the highest percentage of Big Data investments in the healthcare and pharmaceutical industry?

Ask for a Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1581502

Key Findings

The report has the following key findings:

In 2018, Big Data vendors will pocket nearly $4.7 Billion from hardware, software and professional services revenues in the healthcare and pharmaceutical industry. These investments are further expected to grow at a CAGR of approximately 12% over the next three years, eventually accounting for more than $7 Billion by the end of 2021.
Big Data and advanced analytics are driving a paradigm shift in the healthcare and pharmaceutical industry with multiple innovations ranging from precision medicine and digital therapeutics to the adoption of accountable and value-based care models.
Drug developers are making substantial investments in Big Data and artificial intelligence-driven drug discovery platforms to shorten the process of successfully discovering promising compounds. In addition, Big Data technologies are increasingly being utilized to streamline clinical trials, enabling biopharmaceutical companies to significantly lower costs and accelerate productive trials.
The growing adoption of Big Data technologies has also brought about an array of benefits for hospitals and other healthcare facilities. Based on feedback from healthcare providers worldwide, these include but are not limited to cost savings in the range of 20-30%, an increase in patient access to services by more than 35%, growth in revenue by up to 30%, a reduction in emergency room visits by 10%, a drop in patient wait times by 30-60%, improvements in outcomes by as much as 20%, a 10-50% decline in mortality rates for conditions such as heart failure, and a reduction in the occurrence of hospital acquired and surgical site infections by nearly 60%.

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.

Contact:
Hrishikesh Patwardhan
Corporate Headquarters
2nd floor, metropole,
Next to inox theatre,
Bund garden road, Pune-411001.
+1-888-391-5441
[email protected]

Connect With Us on:

Facebook: https://www.facebook.com/ReportsnReports/

LinkedIn: https://www.linkedin.com/company/reportsnreports

Twitter: https://twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml